Large state-wide variation (8.6-fold) in number of clozapine prescriptions per thousand Medicare Part D enrollees in 2017 ^a indicates ≥1.50 SD (18.0) from the mean (33.1... by Luke R. Cavanah (19022435)

Subjects:

Large state-wide variation (8.5-fold) in number of clozapine prescriptions per thousand Medicare Part D enrollees in 2019 ^a indicates ≥1.50 SD (16.8) from the mean (31.0... by Luke R. Cavanah (19022435)

Subjects:

Large state-wide variation (8.6-fold) in number of clozapine prescriptions per thousand Medicare Part D enrollees in 2020 ^a indicates ≥1.50 SD (16.0) from the mean (29.9... by Luke R. Cavanah (19022435)

Subjects:

Large state-wide variation (10.2-fold) in number of clozapine prescriptions per thousand Medicare Part D enrollees in 2016 ^a indicates ≥1.50 SD (19.2) from the mean (34.... by Luke R. Cavanah (19022435)

Subjects:

The correlation between the duration of pain symptoms and baseline serum inflammatory cytokine levels before TFESI. by Pornpan Chalermkitpanit (22110121)

Subjects:

Decrease of cellular cAMP levels in response to a concentration range of melatonin treatments. by Cathryn S. D. Maienza (20629929)

Analysis of variance results (mean sum of squares and significance) for the effect of soil types, crop species, and diuron doses on plant and their interactions on crop growth resp... by Win Win Pyone (20396432)

Sociodemographic characteristics of stroke patients including lost to follow-up/missing data (n = 188). by Farayi Kaseke (19560197)

Subjects:

Patient status overview. by Farayi Kaseke (19560197)

Subjects:

Akaike’s information criterion values for parametric models. by Farayi Kaseke (19560197)

Subjects:

Kaplan-Meier survivor estimates by functional outcome, age group, hospital bill payment and housing status. by Farayi Kaseke (19560197)

Subjects:

Sociodemographic characteristics of stroke patients followed for 12 months (n = 137). by Farayi Kaseke (19560197)

Subjects:

Estimated cumulative hazard against Cox-Snell residuals for the Exponential, Gompertz, Weibull and Lognormal models. by Farayi Kaseke (19560197)

Subjects:

Multivariable Gompertz AFT model for survival status and predictors among stroke patients (n = 137). by Farayi Kaseke (19560197)

Subjects:

Overall Kaplan–Meier survival status among stroke patients. by Farayi Kaseke (19560197)

Subjects:

Composition of the gut microbiota at the genus level following the administration of MP. by Yu Sang Choi (22656230)

Composition of the gut microbiota at the phylum level following the administration of MP. by Yu Sang Choi (22656230)

Increased or reduced ATGL-1 activity does not significantly change <i>N. parisii</i> growth. by Hala Tamim El Jarkass (16625309)

Subjects:

Protective effect of SMND-309 against liver injury in acute liver injury model mice. by Yao Dong (3308124)

Decreased hypotaurine levels within cells lacking the ADO gene in U251 cells. by Hong Tian (169626)